Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 5 Risky Biotechs With Serious Profit Potential
5 Risky Biotechs With Serious Profit Potential
5 Risky Biotechs With Serious Profit Potential
Submitted by
admin
on November 29, 2011 - 1:37pm
Source:
Seeking Alpha
News Tags:
Amgen
Gilead
Spectrum Pharmaceuticals
InterMune
ViroPharma
Headline:
5 Risky Biotechs With Serious Profit Potential
Do Not Allow Advertisers to Use My Personal information
